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RADIATION RISK PREDICTION AND GENETICS: THE INFLUENCE OF THE
TP53 GENE IN VIVO
R. E. J. Mitchel  Radiation Biology and Health Physics Branch, Atomic Energy
of Canada Limited
 Risk prediction and dose limits for human radiation exposure are based on the
assumption that risk is proportional to total dose. However, there is concern about the
appropriateness of those limits for people who may be genetically cancer prone. The TP53
gene product functions in regulatory pathways for DNA repair, cell cycle checkpoints and
apoptosis, processes critical in determining ionizing radiation risk for both carcinogene-
sis and teratogenesis. Mice that are deficient in TP53 function are cancer prone. This
review examines the influence of variations in TP53 gene activity on cancer and terato-
genic risk in mice exposed to radiation in vivo, and compares those observations to the
assumptions and predictions of radiation risk inherent in the existing system of radiation
protection. Current assumptions concerning a linear response with dose, dose additivity,
lack of thresholds and dose rate reduction factors all appear incorrect at low doses. TP53
functional variations can further modify radiation risk from either high or low doses, or
risk from radiation exposures combined with other stresses, and those modifications can
result in both quantitative and qualitative changes in risk. 
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THE LNT HYPOTHESIS AND RISK PREDICTION
The linear no-threshold (LNT) hypothesis is the fundamental basis
for the prediction of risk from radiation exposure, and forms the basis for
radiation protection practices (ICRP 1991). Dose limits for human expo-
sure reflect this assumption that risk is proportional to total dose, without
a threshold. However, radiation protection practices also utilize a number
of additional concepts, derived from or auxiliary to the hypothesis, to pre-
dict the risk of radiation exposure. The most basic concept presumes that
since risk is proportional to dose, then dose can be used as a surrogate for
risk. Additionally, since each dose is assumed to create some risk, those
doses, and hence risks, are treated as additive. Therefore, with the
absence of a threshold, risk can only increase with each dose, and this
assumption applies to low as well as high doses. Importantly however,
radiation protection practices (ICRP 1991) recognize the observation
that different tissues respond differently to radiation, and, based only on
the tissues actually exposed, individually contribute different fractions to
the total risk of radiation. In practice, different tissue types are assigned
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tissue weighting factors (wT) that reflect their relative fractional contri-
bution to the total cancer and non-cancer radiation risk. The wT for each
tissue is held to be constant, independent of dose, since every tissue is
assumed to obey a linear no threshold response. Another concept, also
derived from observation and not the LNT hypothesis, is an assumed 2-
fold reduction in the risk of a high dose/high dose rate exposure, if that
exposure is received at low dose or low dose rate (ICRP 1991). 
The dose limits established by various national bodies make no
allowance for persons who may be at increased risk for genetic reasons,
but simply assume that the limits provide adequate protection for all per-
sons. This approach inherently assumes that the biological response to
radiation of genetically cancer prone individuals is qualitatively similar to
genetically normal individuals, and that a conservative approach to set-
ting dose limits adequately compensates for any quantitative differences.
However, since these assumptions have not been tested in humans, the
concern arises that those risk predictions and hence dose limits may not
be appropriate for genetically cancer prone individuals. If cancer prone
humans were abnormally sensitive to low doses, such as those typical of
public and most occupational exposures, then those persons would be at
higher risk from such exposures. 
Guidance for dealing with this concern in humans may be derived
from the results of animal experiments. The TP53 gene functions in reg-
ulatory pathways for apoptosis, DNA repair and cell cycle delay, all
processes considered to be critical for cellular responses to radiation
damage, and hence for risk of both cancer and teratogenesis (Lee et al.
1994; Saintigny et al. 1999; Coates et al. 2003). Animals with TP53 defects
are cancer prone (Harvey et al. 1993) but mice with constitutively acti-
vated TP53 are almost cancer free (Tyner et al. 2002). Importantly, the
observations of increased cancer risk in mice with TP53 defects are par-
alleled in humans, where a single amino acid change in the p53 protein
(proline for arginine at codon 72) has been shown to impair apoptosis
(Dumont et al. 2003) and result in a 2.5 fold increase in cancer mortality
(van Heemst et al. 2005). Interestingly, the increased cancer risk in
humans with this mutation was accompanied by a 41% increase in survival
in persons over the age of 85, a result again predicted by the previous sim-
ilar mouse study (Tyner et al. 2002). 
The present work reviews the radiation response of animals with
defects in the TP53 gene, and compares those responses to the respons-
es of animals with fully functioning TP53 genes. Two measures of risk are
examined, carcinogenesis and teratogenesis. 
DOSE ADDITIVITY, TP53 AND CARCINOGENESIS
Cancer is considered to be the most important risk associated with
radiation exposure. If the LNT hypothesis is correct, sequential exposures
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to radiation should increase cancer risk for all types of exposures. Figure
1 shows a test of this concept in TP53 normal and heterozygous mice.
Figure 1A shows that in TP53 normal mice exposed to two separate doses,
100 mGy at low dose rate, followed 24h later by exposure to 1 Gy, the laten-
cy for myeloid leukemia was increased as compared to a single 1 Gy expo-
sure (Mitchel et al. 1999). While the frequency for myeloid leukemia was
not different in the two cases, the additional 100 mGy exposure produced
Radiation Risk and the TP53 gene
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FIGURE 1 Cancer risk from sequential 60Co gamma radiation exposures. Panel A. The risk of
myeloid leukemia in TP53 normal mice exposed to 1 Gy or to 100 mGy followed 24h later by 1 Gy.
(Data from Mitchel et al. 1999). Open circles, Control mice without myeloid leukemia; Closed trian-
gles, mice receiving 1 Gy that did not develop myeloid leukemia; Closed circles, mice exposed to 1
Gy that developed myeloid leukemia; Open squares, mice exposed to 100 mGy followed 24h later by
1 Gy that developed myeloid leukemia. Panel B. The risk of lymphoma in cancer prone TP53 het-
erozygous mice exposed to 4 Gy, or 10 or 100 mGy followed 24h later by 4 Gy. (Data from Mitchel et
al. 2004). Open circles, mice not exposed to radiation: Closed circles, mice exposed to 4 Gy at high
dose rate; Open squares, mice exposed to 10 mGy at low dose rate 24h prior to a 4 Gy exposure at
high dose rate; Open triangles, mice exposed to 100 mGy at low dose rate 24h prior to exposure to
4 Gy at high dose rate.
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a protective effect, restoring about half of the life span otherwise lost due
to the induction of this disease by the single 1 Gy exposure. 
Figure 1B shows the results of a similar experiment examining dose
additivity in cancer prone TP53 heterozygous mice (Mitchel et al. 2004).
Two separate exposures, consisting of a dose of 10 mGy at low dose rate
followed 24h later by a dose of 4 Gy, increased lymphoma latency (with-
out a change in frequency) in these cancer prone mice, compared to the
single 4 Gy exposure alone. The additional 10 mGy exposure produced a
protective effect that was qualitatively similar to that observed in the TP53
normal mice. However, in the TP53 heterozygous mice, an increased dose
of 100 mGy prior to a 4 Gy dose did not produce a protective effect as was
seen in the TP53 normal mice with these two exposures. 
These results support one aspect of the risk assumptions used in radi-
ation protection, that cancer proneness modifies only the quantitative
and not the qualitative response to radiation. It indicates therefore, that
the response of normal individuals, with suitable quantitative adjustment,
might be used to predict radiation response and hence risk in cancer
prone individuals. However, both results demonstrate failures in other
assumptions and concepts of risk prediction. The concept of dose addi-
tivity, when at least one exposure is to a low dose at low dose rate, did not
hold, and the concept that risk can only increase as dose increases was
likewise not supported. A comparison of the two results however, shows
the influence of TP53 on cancer risk. In both cases, a low dose at low dose
rate was able to lower the risk associated with a high dose exposure but
reduced TP53 function restricted the upper dose level at which radiation
could provide this protection. Once past this upper dose threshold,
increased dose could increase risk, as currently assumed. 
DOSE ADDITIVITY, TP53 AND TERATOGENESIS
Exposure of a fetus to radiation during the period of organogenesis
can result in malformations. In the murine fetus, a convenient measure
of the severity of the risk of these malformations is tail length at birth,
since the magnitude of the reduction in length reflects the extent of cell
death from the radiation exposure. Figure 2 shows the results of a high
dose and dose rate radiation exposure of pregnant mice during the peri-
od of tail formation (Mitchel et al. 2002). Female mice were bred to
simultaneously contain fetuses that were TP53 normal, TP53 heterozy-
gous and TP53 null. Figure 2A shows that the functional activity of TP53
had a large influence on the risk of radiation-induced tail malformation.
Fetal mice with fully functional TP53 were at the highest risk of tail short-
ening. Reduced TP53 function in the heterozygous fetuses resulted in less
risk, and the complete absence of TP53 function resulted in the least risk.
Similarly, Wang et al. (1999) showed that susceptibility to radiation-
induced apoptosis in the predigital regions and the resulting digital
R. E. J. Mitchel
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defects depended on Trp53 status, with TP53(+/+) mice the most sensi-
tive, TP53(+/–) intermediate, and TP53(–/–) the most resistant. These
results are consistent with the known importance of TP53 dependent
apoptosis as a response to high doses and as a risk determinant for fetal
malformations, but additionally show that a large portion of the risk can
also be attributed to a TP53 independent process. 
At high doses and dose rates, the extent of the malformations in nor-
mal animals is known to be dose dependent, but exhibits an apparent
threshold at about 30-50 cGy (Hossain et al. 1999). However, fetal irradi-
ation with 2 Gy at 1.2 mGy/min was not teratogenic for Trp53(+/+) mice
Radiation Risk and the TP53 gene
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FIGURE 2 Radiation exposure and teratogenesis in fetal mice. (Data from Mitchel et al. 2002).
Panel A. Tail shortening in fetal mice of varying TP53 function exposed to 4 Gy of gamma radiation
delivered at high dose rate on gestational day 11. Panel B. Tail shortening in fetal mice of varying
TP53 function exposed to 0.3 Gy 24h prior to a 4 Gy exposure of gamma radiation delivered at high
dose rate on gestational day 11. Panel C. Tail shortening in fetal mice of varying TP53 function
exposed to 0.3 Gy 24h prior to a 4 Gy exposure of gamma radiation delivered at high dose rate on
gestational day 12. All Panels; Open symbols, control unirradiated fetal mice; Closed symbols, fetal
mice exposed to 4 Gy; Shaded symbols, fetal mice exposed to 0.3 Gy 24h prior to 4 Gy exposure;
Circles TP53 normal; Triangles, TP53 heterozygous; Squares, TP53 null.
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but was teratogenic for Trp53(–/–) mice (Kato et al. 2001). This indicates
that the TP53 gene is indispensable for the threshold effect in the ter-
atogenic risk of radiation at low doses or dose-rates.
These results demonstrate that the risk of fetal malformation as a
result of a high dose exposure is highly dependent on TP53 function, and
that in populations with varying TP53 function, dose is a poor surrogate
for risk. In contrast to the concern of an increased risk of cancer related
to cancer proneness, reduced TP53 function, and the associated cancer
proneness, acts to reduce teratogenic risk at high dose rates but increase
risk at low dose rates. This influence of TP53 could have interesting envi-
ronmental implications. In an environment where pregnant wild mice
may encounter a high dose rate exposure, the reduced teratogenic risk in
fetal variants with reduced TP53 function would tend to increase the
probability that such mice would be born with, for example, all feet and
toes, increasing the probability that they would survive to successfully
breed. Such a situation could put selective pressure for, rather than
against, reduced TP53 function. Conversely, in a situation of low dose rate
environmental exposure, the selective pressure would be reversed.
Aside from the varying risk of malformation associated with varying
TP53 function, the LNT hypothesis would nonetheless predict that the
inherent radiation risk associated with each level of TP53 function should
increase proportionately with increasing dose. A test of this assumption of
dose additivity for each TP53 state is shown in Figure 2B. Two separate
doses, consisting of a dose of 0.3 Gy on gestational day 10 followed by a
dose of 4.0 Gy on gestational day 11, produced effects that varied both
qualitatively and quantitatively with TP53 function. Compared to the sin-
gle 4.0 Gy exposure, the addition of another 0.3 Gy exposure did produce
an increased risk of malformation in the TP53 null fetuses, as predicted
by the LNT assumptions. In contrast however, the additional exposure
reduced risk in the TP53 normal fetuses. A statistically significant, but
much smaller protective effect was seen in the TP53 heterozygous fetus-
es. These results show that for fetal malformations, the concept of dose
additivity, a fundamental assumption of risk prediction, depends entirely
on the functional state of TP53, and only in the highly unusual case of a
complete lack of TP53 function does the risk actually increase in accor-
dance with the current dose additivity concept. The inappropriateness of
the dose additivity concept and the importance of TP53 function in reg-
ulating teratogenic risk is further exemplified by an experiment where
the same two exposures were each given one day later in gestation. Figure
2C shows those results. Since tail development was advanced by one day
of gestation, the magnitude of the tail shortening by the single 4.0 Gy
exposure was less than that seen when the exposure was given one day
earlier (Figure 2A). However, the two-exposure protocol now produced
different results from those seen when the same exposures were given
R. E. J. Mitchel
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one day earlier in gestation. Unlike the protective effects seen in TP53
normal and heterozygotes seen after the one day earlier exposures
(Figure 2B), the additional dose had no effect in these more developed
fetuses (Figure 2C). However, the additional dose now reduced the risk
of malformation in the TP53 null fetuses, unlike the increased risk seen
when the exposures were given earlier in gestation. These data emphasize
that the concepts of dose additivity and increasing risk with increasing
dose do not apply to fetal malformation risk, and that both the direction
of the change and the final magnitude of the risk resulting from an addi-
tional dose is actually determined by a combination of gestational time
and TP53 status.
COMBINED EFFECTS AND TP53
The TP53 gene controls biological processes that are important for
the cellular response to a radiation exposure. These same processes can
also be important for cellular responses to other stresses, and additional-
ly, TP53 is known to regulate normal fetal developmental processes
(Boreham et al. 2002a). As a consequence it could be expected that the
net risk from other stresses combined with a radiation exposure may be
modified by variations in TP53 gene function. Currently, radiation risk
prediction does not include recognition of other risk-modifying factors,
including genetic variations and non-radiation stresses. 
One common stress in humans is fever, and heat is a known mild ter-
atogen in both human (Graham et al. 1998; Martinez-Frias et al. 2001)
and rodent fetuses (Germain et al. 1985; Boreham et al. 2002a) but its ter-
atogenic effect is independent of TP53 status (Boreham et al. 2002a).
Figure 3 shows the effect of the addition of a mild, short duration heat
stress on the teratogenic risk of a high dose radiation exposure in murine
fetuses with varying TP53 function (Boreham et al. 2002b). Exposure of
the fetuses to radiation immediately after a heat stress on gestational day
11 amplified the teratogenic effect of radiation in fetuses lacking TP53
function, but had little or no influence in fetuses with full or partial TP53
function (Figure 3A). In contrast, delaying the radiation exposure by 24h
to gestational day 12 resulted in a large increase in teratogenic risk for
fetuses with either full or partial TP53 function, and a smaller increase in
fetuses without TP53 function (Figure 3B). 
Heat stress can also modify the risk of cancer resulting from a high
dose. In a result analogous to that shown in Figure 1A for a pre-exposure
to a low dose of radiation in TP53 normal mice, exposure to a mild heat
stress followed 24h later by exposure to 1 Gy increased the latency for
myeloid leukemia as compared to the 1 Gy exposure alone. The magni-
tude of this heat-induced protective effect was also similar to the magni-
tude of the protection induced by the low dose radiation exposure.
(Mitchel et al. 1999). 
Radiation Risk and the TP53 gene
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The current system of risk prediction using the LNT hypothesis and
associated assumptions has no basis to allow for these combined effects
with or without the influence of genetic variation.
SINGLE EXPOSURE, THRESHOLDS AND TISSUE WEIGHTING FACTORS
The data shown in Figures 1A and 1B supported the assumption that
the radiation response of cancer prone individuals was qualitatively simi-
lar to that of normal individuals, even though the actual nature of the
response to a low dose was opposite of that predicted by the LNT based
dose additivity concept. TP53 heterozygous mice have a high sponta-
neous cancer frequency and cancers also appear much earlier than in
TP53 normal mice (Harvey et al. 1993). They are therefore useful mod-
els to investigate risk prediction based on the LNT concept of a lack of a
threshold for increased risk after a radiation exposure, and the associat-
ed concept of constancy of tissue weighting factors.
Figure 4 shows the effect of single low dose/low dose rate exposures on
spontaneous cancer formation in the TP53 heterozygous mice (Mitchel et
al. 2003). Figure 4A shows that a single low exposure had the same tumor
latency increasing effect on spontaneous cancers as it did on radiation
induced cancer in TP53 normal mice (Figure 1A) or TP53 heterozygous
mice (Figure 1B). Also as before, the low dose did not alter tumor fre-
R. E. J. Mitchel
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FIGURE 3 Teratogenesis in fetal mice exposed to combined heat and radiation stress. (Data from
Boreham et al. 2002b). Panel A. Tail shortening in fetal mice of varying TP53 function exposed to
4 Gy of gamma radiation delivered at high dose rate on gestational day 11, with or without a heat
stress immediately prior to the radiation exposure. Panel B. Tail shortening in fetal mice of varying
TP53 function exposed to 4 Gy of gamma radiation delivered at high dose rate on gestational day 12,
with or without a prior heat stress on gestational day 11. Heat stress was at 40.5ºC for 60 min. All
Panels; Open symbols, control unirradiated fetal mice; Closed symbols, fetal mice exposed to 4 Gy;
Shaded symbols, fetal mice exposed to heat stress at 40.5ºC for 60 min either immediately or 24h
prior to 4 Gy exposure; Circles TP53 normal; Triangles, TP53 heterozygous; Squares, TP53 null.
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quency. This observation again supports the current operational assump-
tion that cancer proneness does not qualitatively alter radiation response.
However, as was shown in Figure 1 for a low dose added to a high dose, a
single low dose by itself (Figure 4A) did not increase risk, as predicted by
the LNT hypothesis, and therefore risk was not proportional to dose. Since,
in fact, risk decreased below the background risk in these cancer prone
mice, Figure 4A shows that LNT hypothesis also fails at the level of the “no
threshold” component for risk prediction. Clearly, a dose threshold exists
for increased risk from a single radiation exposure. It is also interesting to
note in Figure 4A that both 10 and 100 mGy single doses decreased spon-
taneous cancer risk in the TP53 heterozygous mice, indicating that the
threshold for increased risk was above 100 mGy. This dose threshold for
increased risk was higher than that seen for the same tumor type in the
same animal genotype when the low dose was followed by a high dose
(Figure 1B), indicating that for risk prediction in vivo, the threshold for
increased risk depends not only on the initial dose but also on subsequent
exposure levels. Since all these data support the concept that cancer prone-
ness due to TP53 heterozygosity alters only the quantitative response to
radiation, the data predict that a single exposure would be able to reduce
spontaneous risk in TP53 normal mice at a dose higher than that in Trp53
heterozygous mice. That prediction remains to be tested.
In the TP53 heterozygous mice, a comparison can be made between
the influence of a single radiation exposure on the spontaneous risk of
Radiation Risk and the TP53 gene
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FIGURE 4 The effect of single low dose/low dose rate exposures on spontaneous cancer formation
in TP53 heterozygous mice. (Data from Mitchel et al. 2003). Panel A. Spontaneous lymphoma for-
mation in unexposed TP53 heterozygous mice (closed circles) and in mice with a single exposure to
10 (open triangles) or 100 mGy (open squares) of gamma radiation given at low dose rate to the mice
at 8 weeks of age. Spontaneous lymphoma formation in unexposed TP53 normal mice is shown for
comparison (open circles). Panel B. Spontaneous spinal osteosarcoma formation in unexposed TP53
heterozygous mice (closed circles) and in mice with a single exposure to 10 (open triangles) or 100
mGy (open squares) of gamma radiation given at low dose rate to the mice at 8 weeks of age.
9
Mitchel: Radiation Risk and the TP53 gene
Published by ScholarWorks@UMass Amherst, 2014
lymphomas (Figure 4A) and on the spontaneous risk of osteosarcomas
(Figure 4B). As for lymphomas, a single exposure to 10 mGy decreased
risk by increasing tumor latency. However, unlike the observation for lym-
phomas in these animals, a dose of 100 mGy clearly exceeded the dose
threshold at which risk increases. As for lymphomas, these data make the
(as yet untested) prediction that this dose threshold for osteosarcomas
will also be higher in TP53 normal animals.
The responses depicted in Figure 4 have implications for the LNT
associated concept of using tissue weighting factors in risk prediction
(ICRP 1990). Clearly, the data support the basic concept of tissue weight-
ing factors, in that individual tissues differ in their quantitative response
to radiation. However, equally clearly, the data do not support the con-
cept of a constant wT value for any given tissue. At the dose point where
risk neither increases nor decreases in a given tissue (for example,
between 10 and 100 mGy for bone in the TP53 heterozygous mice), the
wT for that tissue must equal zero; i.e. predict no contribution to the over-
all net risk in the animal. Above that threshold dose the wT would be pos-
itive (i.e. the tissue contributes positively to the net risk in the animal), as
is the current practice. Below the threshold dose, the risk contribution
from the specific tissue must be negative; i.e. there was a protective effect
as the risk was below spontaneous risk. Correspondingly, the wT for that
tissue should be negative, even though the overall net risk to the animal
may be either positive or negative. These data driven considerations for
tissue weighting factors represent a significant departure from the cur-
rent approach for risk prediction at low doses. 
An underlying assumption of the current system for risk prediction is
the idea that biological effects can only occur in tissues that are actually
exposed to radiation. However, it has been known for some time that radi-
ation exposure of one site in the body can result in an antitumor effect
for tumors at other sites, an effect termed the “abscopal effect.” This
“action at a distance” has been shown to be dependent on functional
TP53 (Camphausen et al. 2003), and is a direct indication that the effects
of radiation are not limited to the exposed tissue. These observations sug-
gest that the use of wT for risk prediction based on only the exposed tis-
sue is incorrect. 
DOSE RATE EFFECTS 
An integral part of current radiation risk prediction is an assumed 2-
fold reduction in the risk of an exposure received at low dose rate, com-
pared to high dose rate. Such reductions in risk have been demonstrated
many times after high dose exposures (ICRP 1991). The data shown in
Figures 1,2,4, for both normal and reduced TP53 function indicate that
low doses received at low dose rate reduce risk, but that the reduction
takes the risk below the reference baseline. No matter what the positive
R. E. J. Mitchel
528
10
Dose-Response: An International Journal, Vol. 3 [2014], Iss. 3, Art. 9
https://scholarworks.umass.edu/dose_response/vol3/iss3/9
risk of any high dose rate exposure might be, if the risk associated with a
low dose rate exposure is protective (i.e. less than zero) then the dose rate
reduction factor must be infinity rather than 2. The dose point at which
the dose rate reduction factor becomes infinity must vary with both tissue
type and TP53 status, in concert with the dose threshold (point of zero
risk) under each situation. 
RADIATION WEIGHTING FACTORS, SIEVERTS AND TP53
Ionizing radiation is broadly classified into high or low linear energy
transfer (LET) radiation, based on energy deposition per unit track
length. High LET radiation (for example, alpha radiation) is believed to
have a greater risk per unit of absorbed physical dose (Gy) than low LET
radiation (for example, gamma radiation). Radiation weighting factors
(wR) are defined for high LET radiation to allow dose normalization,
which in turn allows dose (i.e. risk) additivity and hence risk prediction
on a unified basis. Physical doses (Gy) normalized by multiplication with
wR are reported in sievert (Sv) units. Radiation weighting factors repre-
sent the ratio of the biological risk from high LET radiation exposure rel-
ative to the risk from low LET radiation exposure (where low LET radia-
tion wR is defined as = 1). wR are assumed to be constant with dose and
dose rate (ICRP 1991). However, the data shown in Figures 1,2,4 indicates
that risk from a low LET radiation exposure varies as dose decreases, from
increased risk, to no risk, to protection. This indicates that wR for low LET
radiation is not constant with dose and cannot be assigned a wR=1 for all
doses. At the low LET dose threshold for increased risk, wR must be zero
and below that threshold must be a negative number. Consequently wR
values for high LET radiation have no meaning when referenced to a low
LET radiation dose where there is no, or negative, risk. Since animals
with either normal or reduced TP53 function respond qualitatively in the
same way, the use of wR at low doses at or below the “no risk” threshold in
either situation would not be meaningful. Because, however, the thresh-
old dose points are quantitatively different in the two cases of differing
TP53 function, the low dose point at which the use of wR becomes mean-
ingless will differ in those two situations. As a consequence, the data indi-
cate that risk prediction based on dose normalization to sievert units is
also meaningless below these dose points.
CORRELATION OF IN VIVO WITH CELLULAR DATA
The above observations of the influence of TP53 on the effects of low
dose exposure in vivo are consistent with observations of low dose
responses in cells. Low doses of low-LET radiation induce protective
effects and those induced responses have been tightly conserved
throughout evolution, suggesting that they are basic responses critical to
Radiation Risk and the TP53 gene
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life (Mitchel, 2005). Induction of DNA repair, suppression of apoptosis
and protection against radiation and other DNA damaging agents are
central features of this induced response. These responses have been
shown to impact on cancer risk, even as measured in vitro, since low doses
of low LET radiation have been shown to reduce the risk of spontaneous
neoplastic transformation in both rodent (Azzam et al.1996) and human
cells (Redpath and Antonionio, 1998) in culture. In G0 human fibrob-
lasts, high dose rate exposure induced TP53 phosphorylation and H2AX
foci in a dose dependent manner, but low dose rate exposure resulted in
virtually no foci or TP53 phosphorylation, suggesting that the efficient
repair of DNA double strand breaks induced by low dose rate exposure is
linked to TP53 response (Ishizaki et al. 2004). The anti-apoptotic adap-
tive responses seen in vivo have been shown to be related to regulation of
TP53 in the spleens of exposed mice. High dose and dose rate exposure
stimulated TP53 accumulation and apoptosis, but TP53 accumulation was
suppressed, along with apoptosis, after a pre-irradiation at low dose rate
(Takahashi et al. 2001). While TP53 has been shown to be inducible by
very low doses in mice, with increasing response with increasing dose in
both radiation-resistant and radiation-sensitive tissues (MacCallum et al.
2001), the response was heterogeneous between cells, suggesting a cellu-
lar basis for the differential tissue response and tissue specific thresholds
noted here.
CONCLUSIONS
The currently accepted set of assumptions used for the prediction of
risk from a radiation exposure makes no allowance for genetic differ-
ences between individuals or for radiation combined with other stresses.
One particular gene, TP53, has been shown to be important in the bio-
logical processes that control radiation responses for cancer formation
and birth defects. Risk estimate assumptions concerning a linear
response with dose, dose additivity, lack of thresholds and dose rate
reduction factors all appear incorrect at low doses. TP53 functional vari-
ations can further modify radiation risk from either high or low doses, or
risk from radiation exposures combined with other stresses, and those
modifications can result in both quantitative and qualitative changes in
risk, an outcome not accommodated in the current system of radiation
risk prediction. 
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